---
uid: 20260215154100
title: T2D Global Epidemic (422M) Centrally Driven by Insulin Resistance Cascade
authors: Tsoukalas (~2018) + refs
year: 2018
tags: [lit, dt-clinic, diabetes-type2, insulin-resistance, ir-biomarker, phd-biomarker, hidden-hunger, microbiome, stress, calorie-restriction, metabolomics, gc-ms, vitD, adipic-acid, adipic, beta-cell, reversal, ames-triage, phd-ir-adipic]
aliases: [T2D_Epidemic_IR]
status: atomic-strong
parent-moc: [[55-MOCs/MOC_DT_Diabetes_T2D]] | [[22-Dashboards/PhD_IR_MOC]] | [[33-Atomic/Adipic_T2D_IR_Biomarker_20260215_026]]
chain-next: [[33-Atomic/HiddenHunger_T2D_Driver_20260215_018]] | [[33-Atomic/Adipic_T2D_IR_Biomarker_20260215_026]]
confidence: high
cited_refs: [[66-Literature/Diabetes_Type2_Pathogenesis_Tsoukalas_20260215_003]], [[66-Literature/Refs/Refs_CDC_Trends_020]]
---

# T2D_Epidemic_IR_Central_20260215_017

**Strong Claim**: Type 2 Diabetes epidemic (422M cases) is centrally propelled by insulin resistance (IR) from hidden hunger, chronic stress, gut dysbiosis, and sugar overload → beta-cell exhaustion.

**Evidence** (Tsoukalas ~2018 + CDC): 90% T2D = IR → hyperinsulinemia → failure. PhD hook: Adipic acid ↓ as IR biomarker (GC-MS); VitD gaps amplify.

**Implication**: Target IR reversal via metabolomics (174 markers); chain to adipic/VitD protocols.

[[33-Atomic/HiddenHunger_T2D_Driver_20260215_018]] → [[33-Atomic/Adipic_T2D_IR_Biomarker_20260215_026]]